Two more British hospitals relent on vaping prohibitions
24th May 2016 | News analysis |
Two large hospitals in England have become the country’s first to reverse vaping bans.
LATEST ALERTSTwo large hospitals in England have become the country’s first to reverse vaping bans.
The first meeting of an ISO standards committee covering e-cigarettes will take place on 24th October in Osaka, Japan.
A new study has shown some relation between e-cigarette point-of-sale (POS) advertising and youth uptake of e-cigs. But the authors urge people to not jump to conclusions because of the results.
Differing views of nicotine in Britain and the U.S. may underlie a sharp contrast in official attitudes toward e-cigarettes, according to a group of public-health scholars.
New guidance for stop-smoking services in the UK demonstrates how e-cigarettes can contribute to smoking cessation.
In the past year or so, scientists have conducted several systematic reviews that aim to analyse research evidence in order to find whether e-cigs help people quit smoking. The issue addressed by studies like these (which can also be known as meta-analyses) is, of course, one of the primary public-health and policy questions about the devices. But how much value should we place on their findings?
Conflicts of interest in research can blow up when the tobacco industry is seen to be involved in any area of research on smoking – or, now, vaping.
High pricing of e-cigarettes compared to combustibles could deter smokers from switching to vaping in many jurisdictions, a new study suggests.
A new study estimates that somewhere between 16,000 and 22,000 more people have been able to successfully quit conventional cigarettes for at least a year thanks to electronic cigarettes.
The British e-cigarette sector should seek an early review of the Tobacco Products Directive (TPD) rather than continue a doomed fight against this year’s introduction of the new EU rules, a politician has advised.
TV ads seen by young people may lead them to start vaping later, researchers claim in a report which is likely to add further fuel to the debate over e-cigarette marketing – a debate where studies that detect an influence are garnering much more attention than those that suggest advertising is less effectual.
The furore over Sara Kalkhoran and Stanton Glantz’s meta-analysis of e-cigarettes and smoking cessation illustrates some pitfalls in conducting, and interpreting, science. ECigIntelligence takes an in-depth look at the principles and problems behind the statistics.
Medical licensing of an e-cigarette seems to have been decisive in swinging the favour of Britain’s pharmacists toward vaping.
The Welsh Labour party has backed down on a proposal to enact a wide-ranging ban on vaping in public spaces. However, it would still like to see some areas marked as off-limits to vapers.
Are big tobacco companies starting to favour heat-not-burn technology over e-cigarettes? While none has shown any signs of overtly stepping away from e-cigs, and such a move is unlikely, much enthusiasm and investment within the tobacco industry seems to be going toward heat-not-burn.
New age restrictions for e-cigarette products have created some confusion over enforcement and best practice for UK retailers, both online and offline.
Justifications for public vaping bans largely revolve around re-normalisation of conventional smoking as well as the possible health impact of secondhand vaping.
James Higgs of Nicoccino shares his views on marketing, regulation, and education.
Regulators, health professionals and scientists are expected to converge in London this week for an update on research into vaping.
Exclusive insight for ECigIntelligence readers – download a detailed, data-rich presentation on the current state and future of the e-cig industry.
Regulators should set a standard methodology for the pharmacokinetic tests that measure how much nicotine is in vapers’ or smokers’ blood, say scientists at British American Tobacco (BAT).
Experienced users should not be dismissed as unreliable sources of insight when e-cigarettes are being discussed, and their advice can be valuable for those just starting to vape or considering it, according to a British researcher.
Industry executives say e-cig companies are doing the sector a disservice by using sex and cloud chasing to attempt to sell e-cigarettes.
Looking like a regular cigarette is an advantage for e-cig products aiming to poach users away from tobacco, new research suggests.
Counterblasts against Public Health England’s nearly unequivocal support for e-cigarettes were only to be expected, and their trajectory has been laid out by two of Britain’s most eminent general medical journals, The Lancet and The BMJ. But their arguments are neither nuanced nor practical, and are muddled by dislike of the tobacco industry.
There has been little study or comment on e-cigs so far from professional bodies in dental health, or from dental researchers.
But that may now be changing, with increased interest from some corners of the dental profession in e-cigs’ role as potential reducers of harm to oral health.
British American Tobacco (BAT) is expanding its presence in the international e-cigarette market through the acquisition of Poland’s major supplier and formalising its co-operation with U.S. tobacco firm Reynolds American.
A prominent British public-health charity has thrown its weight behind vaping, saying that the public needs educating on e-cigarettes’ health benefits compared with combustibles.
Among all the groups that could benefit from e-cigarettes for harm reduction, perhaps none is as contentious as pregnant women.
British e-cigarette companies can expect an array of new scientific and quality-control costs after the official launch today of the publicly available specification (PAS) for e-cig manufacture and testing from the British Standards Institution (BSI).
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.